Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review
Current Oncology · 05.01.2023 · 30 (1) · 720-748
DOI: 10.3390/curroncol30010056 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Oncology, online erschienen am 05.01.2023. Verfasst von Xiaopei L Zeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Heart, Lung, and Blood Institute of the National Institutes of Health.
Themen: Onkologische Pflege, Kinderkrankenpflege
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and young adults. Treatment is long and involves 2–3 years of a prolonged maintenance phase composed of oral chemotherapies. Adherence to these medications is critical to achieving good outcomes. However, adherence is difficult to determine, as there is currently no consensus on measures of adherence or criteria to determine nonadherence. Furthermore, there have been few studies in pediatric B-ALL describing factors associated with nonadherence. Thus, we performed a systematic review of literature on oral chemotherapy adherence during maintenance therapy in ALL following PRISMA guidelines. Published studies demonstrated various objective and subjective methods of assessing adherence without generalizable definitions of nonadherence. However, the results of these studies suggested that nonadherence to oral maintenance chemotherapy was associated with increased risk of relapse. Future studies of B-ALL therapy should utilize a uniform assessment of adherence and definitions of nonadherence to better determine the impact of nonadherence on B-ALL outcomes and identify predictors of nonadherence that could yield targets for adherence improving interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Division of Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
- Division of Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University of Utah, Salt Lake City, UT 84132, USA.
ORCID-Profile: Mallorie B Heneghan, Sherif M Badawy
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- National Heart, Lung, and Blood Institute of the National Institutes of Health
- NUCATS Voucher Program award
Zitieren
APA
Zeng, X. L., Heneghan, M. B., & Badawy, S. M. (2023). Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review. Current Oncology, 30(1), 720-748. https://doi.org/10.3390/curroncol30010056
Vancouver
Zeng XL, Heneghan MB, Badawy SM. Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review. Current Oncology. 2023;30(1):720-748. doi:10.3390/curroncol30010056
BibTeX
@article{Zeng2023,
author = {Zeng, Xiaopei L and Heneghan, Mallorie B and Badawy, Sherif M},
title = {Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {1},
pages = {720--748},
doi = {10.3390/curroncol30010056}
}
EUVIMED